Cargando…

Compliance with Uresta (CURE) study; a 12 month follow-up of 40 women

INTRODUCTION AND HYPOTHESIS: The Uresta bladder support is an effective management option for women with stress urinary incontinence (SUI), however, there is a lack of data assessing long-term compliance. The aim of this study was to assess compliance at 12 month follow-up in women using the Uresta...

Descripción completa

Detalles Bibliográficos
Autores principales: Campbell, Patrick, Moran, Kayleigh, Boyle, Sinead, Gallagher, Caroline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139490/
https://www.ncbi.nlm.nih.gov/pubmed/35624166
http://dx.doi.org/10.1007/s00192-022-05234-1
_version_ 1784714871332405248
author Campbell, Patrick
Moran, Kayleigh
Boyle, Sinead
Gallagher, Caroline
author_facet Campbell, Patrick
Moran, Kayleigh
Boyle, Sinead
Gallagher, Caroline
author_sort Campbell, Patrick
collection PubMed
description INTRODUCTION AND HYPOTHESIS: The Uresta bladder support is an effective management option for women with stress urinary incontinence (SUI), however, there is a lack of data assessing long-term compliance. The aim of this study was to assess compliance at 12 month follow-up in women using the Uresta bladder support for exercise related SUI. METHODS: This was a prospective study advertised on social media, running clubs and gyms. Participants were fitted with a Uresta bladder support and followed up over a 12 month period. Power calculation recommended a sample size of 43. Ethical approval was obtained. Outcomes were assessed using the PUQ, ICIQ-FLUTS, UDI-6, IIQ-7, QUID and PGI-I questionnaires. RESULTS: Forty-six women were recruited with an average age, BMI and parity of 42, 24 and 2.3 respectively. The most common activities were running (48%) and CrossFit (22%). Six participants withdrew after 2 weeks. Compliance was 90% at 12 months (n=40). Uresta insertion and removal was ‘okay’, ‘easy’ or ‘very easy’ for 86% and 75% respectively. Leakage was improved (n=13), greatly improved (n=12) or stopped (n=5) for 83% of participants, 75% were ‘much better’ or ‘very much better’ on the PGI-I scale, and 94% would recommend Uresta to a friend. There were no adverse events. CONCLUSIONS: The Uresta bladder support is a safe, effective, user-friendly management option for women who experience SUI during exercise with excellent long-term compliance. Further studies are required to identify predictors of successful fitting and efficacy, compare outcomes with different devices, and develop a validated questionnaire assessing SUI with exercise.
format Online
Article
Text
id pubmed-9139490
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-91394902022-06-02 Compliance with Uresta (CURE) study; a 12 month follow-up of 40 women Campbell, Patrick Moran, Kayleigh Boyle, Sinead Gallagher, Caroline Int Urogynecol J Original Article INTRODUCTION AND HYPOTHESIS: The Uresta bladder support is an effective management option for women with stress urinary incontinence (SUI), however, there is a lack of data assessing long-term compliance. The aim of this study was to assess compliance at 12 month follow-up in women using the Uresta bladder support for exercise related SUI. METHODS: This was a prospective study advertised on social media, running clubs and gyms. Participants were fitted with a Uresta bladder support and followed up over a 12 month period. Power calculation recommended a sample size of 43. Ethical approval was obtained. Outcomes were assessed using the PUQ, ICIQ-FLUTS, UDI-6, IIQ-7, QUID and PGI-I questionnaires. RESULTS: Forty-six women were recruited with an average age, BMI and parity of 42, 24 and 2.3 respectively. The most common activities were running (48%) and CrossFit (22%). Six participants withdrew after 2 weeks. Compliance was 90% at 12 months (n=40). Uresta insertion and removal was ‘okay’, ‘easy’ or ‘very easy’ for 86% and 75% respectively. Leakage was improved (n=13), greatly improved (n=12) or stopped (n=5) for 83% of participants, 75% were ‘much better’ or ‘very much better’ on the PGI-I scale, and 94% would recommend Uresta to a friend. There were no adverse events. CONCLUSIONS: The Uresta bladder support is a safe, effective, user-friendly management option for women who experience SUI during exercise with excellent long-term compliance. Further studies are required to identify predictors of successful fitting and efficacy, compare outcomes with different devices, and develop a validated questionnaire assessing SUI with exercise. Springer International Publishing 2022-05-27 2023 /pmc/articles/PMC9139490/ /pubmed/35624166 http://dx.doi.org/10.1007/s00192-022-05234-1 Text en © Crown 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Article
Campbell, Patrick
Moran, Kayleigh
Boyle, Sinead
Gallagher, Caroline
Compliance with Uresta (CURE) study; a 12 month follow-up of 40 women
title Compliance with Uresta (CURE) study; a 12 month follow-up of 40 women
title_full Compliance with Uresta (CURE) study; a 12 month follow-up of 40 women
title_fullStr Compliance with Uresta (CURE) study; a 12 month follow-up of 40 women
title_full_unstemmed Compliance with Uresta (CURE) study; a 12 month follow-up of 40 women
title_short Compliance with Uresta (CURE) study; a 12 month follow-up of 40 women
title_sort compliance with uresta (cure) study; a 12 month follow-up of 40 women
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139490/
https://www.ncbi.nlm.nih.gov/pubmed/35624166
http://dx.doi.org/10.1007/s00192-022-05234-1
work_keys_str_mv AT campbellpatrick compliancewithurestacurestudya12monthfollowupof40women
AT morankayleigh compliancewithurestacurestudya12monthfollowupof40women
AT boylesinead compliancewithurestacurestudya12monthfollowupof40women
AT gallaghercaroline compliancewithurestacurestudya12monthfollowupof40women